| Manuel A Rivera, MD | |
|
4536 22nd Ave, Kenosha, WI 53140-5917 | |
| (262) 656-0044 | |
| (262) 653-2218 |
| Full Name | Manuel A Rivera |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 41 Years |
| Location | 4536 22nd Ave, Kenosha, Wisconsin |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184690133 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207PE0004X | Emergency Medicine - Emergency Medical Services | H0762 (Texas) | Secondary |
| 207R00000X | Internal Medicine | 26699 (Wisconsin) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kenosha Community Health Center, Inc. | 0941195168 | 10 |
News Archive
Vanderbilt researchers have been selected to receive a national grant as part of a push to gauge the coming impact of the Affordable Care Act (ACA).
A clinical study conducted at Henry Ford Hospital on the use of a drug to extend the survival of patients with the most common and aggressive type of brain cancer, has yielded results that were significantly better than expected.
Ninety per cent of older persons in rural Bangladesh displayed either overt or risk for malnutrition in a collaborative study presented in a dissertation by Tamanna Ferdous from Uppsala University Sept 22, 2009. The results, which are part of a larger international study, challenge the Millenium Development Goals.
Ligand Pharmaceuticals Incorporated today announced that it will receive a $2 million milestone payment from Merck, known as MSD outside the United States and Canada, under the terms of a development and license collaboration for the development of dinaciclib.
› Verified 3 days ago
| Entity Name | Moundview Memorial Hospital & Clinics Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710939533 PECOS PAC ID: 1355250432 Enrollment ID: O20031121000846 |
News Archive
Vanderbilt researchers have been selected to receive a national grant as part of a push to gauge the coming impact of the Affordable Care Act (ACA).
A clinical study conducted at Henry Ford Hospital on the use of a drug to extend the survival of patients with the most common and aggressive type of brain cancer, has yielded results that were significantly better than expected.
Ninety per cent of older persons in rural Bangladesh displayed either overt or risk for malnutrition in a collaborative study presented in a dissertation by Tamanna Ferdous from Uppsala University Sept 22, 2009. The results, which are part of a larger international study, challenge the Millenium Development Goals.
Ligand Pharmaceuticals Incorporated today announced that it will receive a $2 million milestone payment from Merck, known as MSD outside the United States and Canada, under the terms of a development and license collaboration for the development of dinaciclib.
› Verified 3 days ago
| Entity Name | Kenosha Community Health Center, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265435960 PECOS PAC ID: 0941195168 Enrollment ID: O20040217000840 |
News Archive
Vanderbilt researchers have been selected to receive a national grant as part of a push to gauge the coming impact of the Affordable Care Act (ACA).
A clinical study conducted at Henry Ford Hospital on the use of a drug to extend the survival of patients with the most common and aggressive type of brain cancer, has yielded results that were significantly better than expected.
Ninety per cent of older persons in rural Bangladesh displayed either overt or risk for malnutrition in a collaborative study presented in a dissertation by Tamanna Ferdous from Uppsala University Sept 22, 2009. The results, which are part of a larger international study, challenge the Millenium Development Goals.
Ligand Pharmaceuticals Incorporated today announced that it will receive a $2 million milestone payment from Merck, known as MSD outside the United States and Canada, under the terms of a development and license collaboration for the development of dinaciclib.
› Verified 3 days ago
| Entity Name | Moundview Memorial Hospital & Clinics Inc |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1710939533 PECOS PAC ID: 1355250432 Enrollment ID: O20070525000443 |
News Archive
Vanderbilt researchers have been selected to receive a national grant as part of a push to gauge the coming impact of the Affordable Care Act (ACA).
A clinical study conducted at Henry Ford Hospital on the use of a drug to extend the survival of patients with the most common and aggressive type of brain cancer, has yielded results that were significantly better than expected.
Ninety per cent of older persons in rural Bangladesh displayed either overt or risk for malnutrition in a collaborative study presented in a dissertation by Tamanna Ferdous from Uppsala University Sept 22, 2009. The results, which are part of a larger international study, challenge the Millenium Development Goals.
Ligand Pharmaceuticals Incorporated today announced that it will receive a $2 million milestone payment from Merck, known as MSD outside the United States and Canada, under the terms of a development and license collaboration for the development of dinaciclib.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Manuel A Rivera, MD 4006 Washington Rd, Kenosha, WI 53144-4819 Ph: (262) 656-0044 | Manuel A Rivera, MD 4536 22nd Ave, Kenosha, WI 53140-5917 Ph: (262) 656-0044 |
News Archive
Vanderbilt researchers have been selected to receive a national grant as part of a push to gauge the coming impact of the Affordable Care Act (ACA).
A clinical study conducted at Henry Ford Hospital on the use of a drug to extend the survival of patients with the most common and aggressive type of brain cancer, has yielded results that were significantly better than expected.
Ninety per cent of older persons in rural Bangladesh displayed either overt or risk for malnutrition in a collaborative study presented in a dissertation by Tamanna Ferdous from Uppsala University Sept 22, 2009. The results, which are part of a larger international study, challenge the Millenium Development Goals.
Ligand Pharmaceuticals Incorporated today announced that it will receive a $2 million milestone payment from Merck, known as MSD outside the United States and Canada, under the terms of a development and license collaboration for the development of dinaciclib.
› Verified 3 days ago
Hanna Mariani, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6308 8th Ave, Ste 3070, Kenosha, WI 53143 Phone: 262-656-3710 Fax: 262-656-3715 | |
Leilane U Sta Romana, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 6127 Green Bay Rd, #200, Kenosha, WI 53142 Phone: 262-658-3706 Fax: 262-658-1751 | |
Raymond W Knight, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 6308 8th Ave, Ste 2000, Kenosha, WI 53143 Phone: 262-653-5300 Fax: 262-653-5412 | |
Dr. Rodrigo Buencamino Mata Iii, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6123 Green Bay Rd, Suite 120, Kenosha, WI 53142 Phone: 262-652-2710 | |
Michael H Zeihen, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6308 8th Ave, Suite 2000, Kenosha, WI 53143 Phone: 262-653-5300 Fax: 262-653-5412 | |
Zebi Fatima, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 10400 75th St, Kenosha, WI 53142 Phone: 262-942-5600 | |
Timothy A. Sanborn, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6308 8th Ave, Kenosha, WI 53143 Phone: 262-653-3650 Fax: 262-656-3672 |